Quality Assessment: Sustained Growth and Financial Strength
Sharda Cropchem’s quality rating has been bolstered by its impressive financial performance over recent quarters. The company remains net-debt free, a critical indicator of financial health and operational efficiency. Its net sales have grown at a compounded annual rate of 18.17%, while operating profit has increased at 19.11% annually, signalling robust business fundamentals.
Notably, the company reported a remarkable 365.99% growth in net profit in the latest quarter, with PAT for the first nine months of FY25-26 reaching ₹362.21 crores, up 259.30% year-on-year. PBT excluding other income stood at ₹157.32 crores, reflecting a 247.21% increase. Net sales for the same period surged 28.55% to ₹3,202.68 crores. These figures underscore a consistent upward trajectory, with positive results declared for seven consecutive quarters.
Return on Equity (ROE) stands at a healthy 16.9%, indicating efficient utilisation of shareholder capital. The company’s strong fundamentals place it among the top 1% of all 4,000 stocks rated by MarketsMojo, ranking 13th among small caps and 34th across the entire market.
Valuation: Fair Yet Premium Amidst Growth
Sharda Cropchem’s valuation metrics reflect a fair but premium stance relative to its peers. The stock trades at a Price to Book (P/B) ratio of 3.8, which, while above average, is justified by its superior growth and profitability metrics. The company’s Price/Earnings to Growth (PEG) ratio is an attractive 0.1, signalling undervaluation relative to its earnings growth potential.
Over the past year, the stock has generated a return of 105.89%, significantly outperforming the Sensex, which declined by 2.41% over the same period. This market-beating performance is supported by a 131.6% rise in profits, reinforcing the premium valuation as reasonable and supported by fundamentals.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Financial Trend: Exceptional Growth Momentum
The financial trend for Sharda Cropchem has been overwhelmingly positive, driven by strong operational execution and market demand. The company’s net sales and profits have demonstrated sustained double-digit growth over multiple years. The 9-month PAT growth of 259.30% and PBT growth of 247.21% highlight accelerating profitability.
Long-term returns further validate this trend. Over the last five years, the stock has delivered a staggering 265.76% return, vastly outperforming the Sensex’s 57.94% gain. Over ten years, the stock’s return of 329.02% dwarfs the Sensex’s 196.59%. This consistent outperformance reflects the company’s ability to generate shareholder value through growth and profitability.
Such financial momentum supports the upgrade in the financial trend rating, signalling confidence in the company’s future earnings trajectory and cash flow generation.
Technicals: Shift to Bullish Momentum
The upgrade to Strong Buy was also driven by a marked improvement in technical indicators. The technical grade shifted from mildly bullish to bullish, reflecting stronger price momentum and positive market sentiment.
Key technical signals include a bullish daily moving average and Bollinger Bands indicating upward price pressure on both weekly and monthly charts. The monthly MACD and KST indicators are bullish, while weekly MACD remains mildly bearish but is outweighed by other positive signals. The On-Balance Volume (OBV) on the monthly chart is bullish, suggesting accumulation by investors.
Price action supports this technical optimism. The stock closed at ₹1,124.90 on 27 April 2026, up 1.34% from the previous close of ₹1,110.00, with a day’s high of ₹1,141.45. It remains comfortably above its 52-week low of ₹440.05 and is approaching its 52-week high of ₹1,297.80.
These technical improvements indicate a strong likelihood of continued upward price movement, justifying the upgrade in technical rating and the overall Strong Buy recommendation.
Thinking about Sharda Cropchem Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this small-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Market Position and Shareholder Confidence
Sharda Cropchem’s market capitalisation classifies it as a small-cap stock, yet it ranks impressively within this category. It is positioned 13th among small caps and 34th across the entire market in the MarketsMojo ratings, reflecting strong investor confidence and market recognition.
The company’s promoters remain the majority shareholders, signalling stable ownership and aligned interests with minority investors. This shareholder structure often supports long-term strategic planning and consistent performance.
Comparative returns further highlight the company’s market-beating credentials. Over one week, the stock gained 2.12% while the Sensex declined 1.55%. Over one month, Sharda Cropchem surged 23.00% against the Sensex’s 5.06%. Year-to-date, the stock has risen 28.66%, contrasting with the Sensex’s 9.29% decline. These figures demonstrate strong relative strength and resilience in volatile markets.
Conclusion: A Compelling Investment Proposition
The upgrade of Sharda Cropchem Ltd’s investment rating to Strong Buy is well justified by a confluence of factors. The company’s quality metrics reveal sustained growth, profitability, and a net-debt free balance sheet. Valuation remains fair despite a premium, supported by exceptional earnings growth and a low PEG ratio. Financial trends indicate accelerating momentum, while technical indicators have shifted decisively bullish, signalling positive price action ahead.
Investors seeking exposure to the pesticides and agrochemicals sector would find Sharda Cropchem a compelling pick, combining strong fundamentals with attractive market positioning and technical strength. The company’s consistent track record of positive quarterly results and market-beating returns further reinforce its appeal as a reliable growth stock in the small-cap universe.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
